Imperial Valley News
Sacramento, California - California Department of Public Health (CDPH) Director and State Health Officer Dr. Karen Smith announced that the department has been notified of a presumptive positive case of plague contracted by a recent visitor to California from Georgia. Confirmatory testing is being conducted by the Centers for Disease Control and Prevention (CDC). Prior to becoming ill, the patient had been vacationing in Yosemite National Park (Yosemite), the Sierra National Forest and surrounding areas in California in early August.
death Valley, California - August 25. Come to the park and view the spectacular night sky, hike a peak, or see the lowest spot in North America.
Washington, DC - The United States welcomes the signing yesterday by the opposition and other stakeholders of the South Sudan peace agreement. However, we are deeply disappointed that the Government of South Sudan under President Kiir yet again squandered the opportunity to bring peace to their people by refusing to sign the agreement. The U.S. deplores this failure of leadership.
Washington, DC - Special Envoy for the Great Lakes Region of Africa Thomas Perriello will return to the region on August 18 to visit Rwanda, Tanzania, the Democratic Republic of the Congo (D.R.C.), and Angola. The Special Envoy's trip will focus on upcoming elections in the region in furtherance of President Obama's policy in support of democratic transitions. Special Envoy Perriello will also engage regional leaders on continued efforts to address the deteriorating situation in Burundi.
Sacramento, California - Governor Brown signed the Workforce Investment for the Re-Entry Population (AB 1093) bill today, which was authored by local Assemblymember Eduardo Garcia (D-Coachella). The legislation modifies the criteria for the Supervised Population Workforce Training Grant Program and allows grant applicants to address the education and training needs of people who have some postsecondary education or individuals who require basic education.
Washington, DC - The U.S. Food and Drug Administration today approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Prior to Addyi’s approval, there were no FDA-approved treatments for sexual desire disorders in men or women.